Long Acting Self Administered HIV Therapy with CCR5 Antibody PRO 140

Grant

Date/time Interval

  • May 1, 2014 - April 30, 2015
  • Total Award Amount

  • 5647.00
  • Direct Costs

  • 3842.00
  • Sponsor Award Id

  • 220603_UAB
  • Contributor

  • Edward Acosta Pharm.D.   Principal Investigator